Does levodopa affect metaiodobenzylguanidine myocardial accumulation in Parkinson's disease?
Identifieur interne : 001692 ( Main/Exploration ); précédent : 001691; suivant : 001693Does levodopa affect metaiodobenzylguanidine myocardial accumulation in Parkinson's disease?
Auteurs : Masahiko Kishi [Japon] ; Ryuji Sakakibara [Japon] ; Hitoshi Terada [Japon] ; Emina Ogawa [Japon] ; Terada Tateno [Japon]Source :
- Movement Disorders [ 0885-3185 ] ; 2011-02-15.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- 3-Iodobenzylguanidine (metabolism), Aged, Aged, 80 and over, Antiparkinson Agents (pharmacology), Antiparkinson Agents (therapeutic use), Female, Humans, Levodopa, Levodopa (pharmacology), Levodopa (therapeutic use), Male, Middle Aged, Myocardial disease, Myocardium (metabolism), Nervous system diseases, Parkinson Disease (drug therapy), Parkinson Disease (pathology), Parkinson disease, Radionuclide Imaging (methods).
- MESH :
- chemical , metabolism : 3-Iodobenzylguanidine.
- chemical , pharmacology : Antiparkinson Agents, Levodopa.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- drug therapy : Parkinson Disease.
- metabolism : Myocardium.
- methods : Radionuclide Imaging.
- pathology : Parkinson Disease.
- Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged.
Url:
DOI: 10.1002/mds.23464
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002623
- to stream Istex, to step Curation: 002623
- to stream Istex, to step Checkpoint: 000425
- to stream PubMed, to step Corpus: 001467
- to stream PubMed, to step Curation: 001467
- to stream PubMed, to step Checkpoint: 001366
- to stream Ncbi, to step Merge: 002F53
- to stream Ncbi, to step Curation: 002F53
- to stream Ncbi, to step Checkpoint: 002F53
- to stream Main, to step Merge: 001746
- to stream PascalFrancis, to step Corpus: 000665
- to stream PascalFrancis, to step Curation: 002653
- to stream PascalFrancis, to step Checkpoint: 000625
- to stream Main, to step Merge: 001C15
- to stream Main, to step Curation: 001692
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Does levodopa affect metaiodobenzylguanidine myocardial accumulation in Parkinson's disease?</title>
<author><name sortKey="Kishi, Masahiko" sort="Kishi, Masahiko" uniqKey="Kishi M" first="Masahiko" last="Kishi">Masahiko Kishi</name>
</author>
<author><name sortKey="Sakakibara, Ryuji" sort="Sakakibara, Ryuji" uniqKey="Sakakibara R" first="Ryuji" last="Sakakibara">Ryuji Sakakibara</name>
</author>
<author><name sortKey="Terada, Hitoshi" sort="Terada, Hitoshi" uniqKey="Terada H" first="Hitoshi" last="Terada">Hitoshi Terada</name>
</author>
<author><name sortKey="Ogawa, Emina" sort="Ogawa, Emina" uniqKey="Ogawa E" first="Emina" last="Ogawa">Emina Ogawa</name>
</author>
<author><name sortKey="Tateno, Terada" sort="Tateno, Terada" uniqKey="Tateno T" first="Terada" last="Tateno">Terada Tateno</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8EF40092DDC139895F01933EE610B585497AE13B</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1002/mds.23464</idno>
<idno type="url">https://api.istex.fr/document/8EF40092DDC139895F01933EE610B585497AE13B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002623</idno>
<idno type="wicri:Area/Istex/Curation">002623</idno>
<idno type="wicri:Area/Istex/Checkpoint">000425</idno>
<idno type="wicri:doubleKey">0885-3185:2011:Kishi M:does:levodopa:affect</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:21287597</idno>
<idno type="wicri:Area/PubMed/Corpus">001467</idno>
<idno type="wicri:Area/PubMed/Curation">001467</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001366</idno>
<idno type="wicri:Area/Ncbi/Merge">002F53</idno>
<idno type="wicri:Area/Ncbi/Curation">002F53</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002F53</idno>
<idno type="wicri:Area/Main/Merge">001746</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:11-0211314</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000665</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002653</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000625</idno>
<idno type="wicri:doubleKey">0885-3185:2011:Kishi M:does:levodopa:affect</idno>
<idno type="wicri:Area/Main/Merge">001C15</idno>
<idno type="wicri:Area/Main/Curation">001692</idno>
<idno type="wicri:Area/Main/Exploration">001692</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Does levodopa affect metaiodobenzylguanidine myocardial accumulation in Parkinson's disease?</title>
<author><name sortKey="Kishi, Masahiko" sort="Kishi, Masahiko" uniqKey="Kishi M" first="Masahiko" last="Kishi">Masahiko Kishi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Internal Medicine Neurology Division, Sakura Medical Center Toho University, Sakura</wicri:regionArea>
<wicri:noRegion>Sakura</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sakakibara, Ryuji" sort="Sakakibara, Ryuji" uniqKey="Sakakibara R" first="Ryuji" last="Sakakibara">Ryuji Sakakibara</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Internal Medicine Neurology Division, Sakura Medical Center Toho University, Sakura</wicri:regionArea>
<wicri:noRegion>Sakura</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Terada, Hitoshi" sort="Terada, Hitoshi" uniqKey="Terada H" first="Hitoshi" last="Terada">Hitoshi Terada</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Radiology, Sakura Medical Center Toho University, Sakura</wicri:regionArea>
<wicri:noRegion>Sakura</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ogawa, Emina" sort="Ogawa, Emina" uniqKey="Ogawa E" first="Emina" last="Ogawa">Emina Ogawa</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Internal Medicine Neurology Division, Sakura Medical Center Toho University, Sakura</wicri:regionArea>
<wicri:noRegion>Sakura</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tateno, Terada" sort="Tateno, Terada" uniqKey="Tateno T" first="Terada" last="Tateno">Terada Tateno</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Internal Medicine Neurology Division, Sakura Medical Center Toho University, Sakura</wicri:regionArea>
<wicri:noRegion>Sakura</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2011-02-15">2011-02-15</date>
<biblScope unit="vol">26</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="564">564</biblScope>
<biblScope unit="page" to="565">565</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">8EF40092DDC139895F01933EE610B585497AE13B</idno>
<idno type="DOI">10.1002/mds.23464</idno>
<idno type="ArticleID">MDS23464</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>3-Iodobenzylguanidine (metabolism)</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Antiparkinson Agents (pharmacology)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Female</term>
<term>Humans</term>
<term>Levodopa</term>
<term>Levodopa (pharmacology)</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Myocardial disease</term>
<term>Myocardium (metabolism)</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (pathology)</term>
<term>Parkinson disease</term>
<term>Radionuclide Imaging (methods)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>3-Iodobenzylguanidine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Myocardium</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Radionuclide Imaging</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Lévodopa</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
<term>Pathologie du myocarde</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Japon</li>
</country>
</list>
<tree><country name="Japon"><noRegion><name sortKey="Kishi, Masahiko" sort="Kishi, Masahiko" uniqKey="Kishi M" first="Masahiko" last="Kishi">Masahiko Kishi</name>
</noRegion>
<name sortKey="Ogawa, Emina" sort="Ogawa, Emina" uniqKey="Ogawa E" first="Emina" last="Ogawa">Emina Ogawa</name>
<name sortKey="Sakakibara, Ryuji" sort="Sakakibara, Ryuji" uniqKey="Sakakibara R" first="Ryuji" last="Sakakibara">Ryuji Sakakibara</name>
<name sortKey="Tateno, Terada" sort="Tateno, Terada" uniqKey="Tateno T" first="Terada" last="Tateno">Terada Tateno</name>
<name sortKey="Terada, Hitoshi" sort="Terada, Hitoshi" uniqKey="Terada H" first="Hitoshi" last="Terada">Hitoshi Terada</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001692 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001692 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:8EF40092DDC139895F01933EE610B585497AE13B |texte= Does levodopa affect metaiodobenzylguanidine myocardial accumulation in Parkinson's disease? }}
This area was generated with Dilib version V0.6.23. |